A limited tour of SKTO the mother ship. A small glimpse of an MMJ brand and licensing giant in its budding stage of growth.
On May 21, 2013 , SK3 Group signed an agreement with Alternative Energy Partners, Inc (“AEGY”) to become the exclusive online and phone application marketing platform for the collectives managed by SK3 Group.
As of Nov. 25, 2013 , SKTO has distribution agreements with over 400 collectives and dispensaries and counting.
01/25/2013 SK3 Group, Inc's (SKTO) subsidiary Medical Greens is pleased to announce that its managed wholesale collectives portfolio has reached a new distribution agreement for the sale of the Company's products in over 400 collectives throughout California.
"SK3 Group has secured an aggregate of over 50 acres of real estate in California to manage stateof-the-art growing facilities for medicinal cannabis."
01/08/2014 SK3 Group, Inc's (SKTO) subsidiary Medical Greens announces it has signed a new management contract with medical marijuana growers that have an aggregate of over 12,000 square feet of indoor cultivation in California, in full compliance with state medical marijuana laws and guidelines.
"This agreement provides an exclusive supply of high-CBD raw materials that is a key ingredient in various products that the Company (SKTO) has licensed to its Wholesale Managed Collectives."
Janes Prepaid Card
Jan 31, 2014) - SK3 Group, Inc's (SKTO) subsidiary Medical Greens is pleased to announce that it has officially launched its Janes Card™ benefits and payment card. The Janes Card™ is a universal benefits-based prepaid card along with a payment solution and rewards program that is intended to build customer loyalty for all retailers that accept it throughout California.
http://www.janescard.com
Sovereign Int'l
On August 16, 2013, the Company signed a definitive agreement to acquire Sovereign International, Inc., a full service medical cannabis consulting firm specializing in advising on cultivation techniques.
Berkeley Bio:
On June 30, 2013 , SK3 Group (SKTO) closed an acquisition agreement to acquire 100% of the outstanding shares of BBORL, INC (Berkeley Bio-Organic Research Laboratories), a
California Corporation for 20 million shares of SK3 Group common stock.
SKTO owns Berkeley Bio including all of its intellectual property.
Berkeley Bio:
Development and production of cannabinoid medicines manufactured under license by SKTO's managed wholesale collectives.
Development and production of equipment for the manufacture and production of cannabinoid-based medicines.
On July 29, 2013 , the Company obtained licenses for several proprietary technologies for the
extraction, purification, and creation of medicines consisting of cannabinoids from marijuana and hemp. Cannabinoids are a natural substance with medicinal benefits found in cannabis.
01/24/2014 SK3 Group, Inc (OTC Pink: SKTO) is pleased to announce that it has completed the licensing agreements between Berkeley Bio-Organic Research Laboratories, LLC and its managed wholesale collectives to produce non-psychoactive mixed cannabinoid carboxylates (Dharmanol™).
"Dr. Charles Apel and David Hoye have developed a unique technique for extracting the non-psychoactive but effective components of cannabis that we believe will prove to be the key to bringing an entirely new dimension to the field of nutritional supplements in the United States and greater access to the beneficial effects of medical marijuana. We are happy to have put together more of the elements necessary to fill the large demand anticipated for our Dharmanol™ product line,"
Yak and Yeti lines and SKTO's potential blockbuster Dharmanol (with others to follow) were created by those at Berkeley Bio. Since about 1970, GoldNApel now of BB were building a launching pad -- actualized by years of science, research, experimentation, and hospice experience -- for the medical cannabis renaissance of today. Without these individuals and their tenacity and vision, the present MMJ revolution, which holds the promise of significantly reducing human suffering and substantially lowering medical costs, might have been delayed another decade.
Monarch Vaporizer Pens (Vapes)
Jan 29, 2014 - SK3 Group, Inc.'s (SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that it has signed an exclusive distribution agreement for the Monarch Vaporizer from Monarch Vapes, a provider of portable personal vaporizers.
From 11/05/2013 conference call.
"We have management contracts in place to provide various managerial services and licenses to collectives that own or manufacture the medicines.
Our management contracts are a) with retail managed collectives that sell directly to patients and b) with wholesale managed collectives that take the raw material, that contains the medicine, and manufacture it into finished products, licensed in respect to manufacturing and marketing, and then sell these finished products to other dispensaries.
The wholesale managed collectives pay us a license fee for the intellectual property rights of products and processes for the creation of products such as Dharmanol and Canna-Loz, which license includes the right to use the name of the product and the formula for producing it.
Now, a great deal of time, effort and expertise have gone into developing these production methods so that they result in consistent products.
The beauty behind this whole thing is that we're exploiting these assets as licensors and consultants in the industry."
For Q3 (July 1 - Sept 30, 2013) per conference call 11/05/2013.
$17,527,592 in consulting, licensing and management fees
$4,510,893 net income pre-tax or $.0076/sh
O/S (inferred) 593,538,552 shares
Balance sheet
$129,865 cash and cash eqivalents
Receivables: net $22,569,699 after a reserve for $12,706,300 was established
On May 21, 2013 , SK3 Group signed an agreement with Alternative Energy Partners, Inc (“AEGY”) to become the exclusive online and phone application marketing platform for the collectives managed by SK3 Group.
As of Nov. 25, 2013 , SKTO has distribution agreements with over 400 collectives and dispensaries and counting.
01/25/2013 SK3 Group, Inc's (SKTO) subsidiary Medical Greens is pleased to announce that its managed wholesale collectives portfolio has reached a new distribution agreement for the sale of the Company's products in over 400 collectives throughout California.
"SK3 Group has secured an aggregate of over 50 acres of real estate in California to manage stateof-the-art growing facilities for medicinal cannabis."
01/08/2014 SK3 Group, Inc's (SKTO) subsidiary Medical Greens announces it has signed a new management contract with medical marijuana growers that have an aggregate of over 12,000 square feet of indoor cultivation in California, in full compliance with state medical marijuana laws and guidelines.
"This agreement provides an exclusive supply of high-CBD raw materials that is a key ingredient in various products that the Company (SKTO) has licensed to its Wholesale Managed Collectives."
These managed medical cannabis growers are currently in the process of switching to cultivating non-psychoactive strains of medical marijuana that are high in the non-psychoactive cannabinoid Cannabidiol (commonly abbreviated CBD). These non-psychoactive high-CBD strains are primarily used for medicinal purposes.
"We believe that the market for non-psychoactive medical marijuana products is many times the size of the market for the highly psychoactive medical marijuana products that are currently available. "Janes Prepaid Card
Jan 31, 2014) - SK3 Group, Inc's (SKTO) subsidiary Medical Greens is pleased to announce that it has officially launched its Janes Card™ benefits and payment card. The Janes Card™ is a universal benefits-based prepaid card along with a payment solution and rewards program that is intended to build customer loyalty for all retailers that accept it throughout California.
http://www.janescard.com
Sovereign Int'l
On August 16, 2013, the Company signed a definitive agreement to acquire Sovereign International, Inc., a full service medical cannabis consulting firm specializing in advising on cultivation techniques.
Berkeley Bio:
On June 30, 2013 , SK3 Group (SKTO) closed an acquisition agreement to acquire 100% of the outstanding shares of BBORL, INC (Berkeley Bio-Organic Research Laboratories), a
California Corporation for 20 million shares of SK3 Group common stock.
SKTO owns Berkeley Bio including all of its intellectual property.
Berkeley Bio:
Development and production of cannabinoid medicines manufactured under license by SKTO's managed wholesale collectives.
Development and production of equipment for the manufacture and production of cannabinoid-based medicines.
On July 29, 2013 , the Company obtained licenses for several proprietary technologies for the
extraction, purification, and creation of medicines consisting of cannabinoids from marijuana and hemp. Cannabinoids are a natural substance with medicinal benefits found in cannabis.
01/24/2014 SK3 Group, Inc (OTC Pink: SKTO) is pleased to announce that it has completed the licensing agreements between Berkeley Bio-Organic Research Laboratories, LLC and its managed wholesale collectives to produce non-psychoactive mixed cannabinoid carboxylates (Dharmanol™).
"Dr. Charles Apel and David Hoye have developed a unique technique for extracting the non-psychoactive but effective components of cannabis that we believe will prove to be the key to bringing an entirely new dimension to the field of nutritional supplements in the United States and greater access to the beneficial effects of medical marijuana. We are happy to have put together more of the elements necessary to fill the large demand anticipated for our Dharmanol™ product line,"
Yak and Yeti lines and SKTO's potential blockbuster Dharmanol (with others to follow) were created by those at Berkeley Bio. Since about 1970, GoldNApel now of BB were building a launching pad -- actualized by years of science, research, experimentation, and hospice experience -- for the medical cannabis renaissance of today. Without these individuals and their tenacity and vision, the present MMJ revolution, which holds the promise of significantly reducing human suffering and substantially lowering medical costs, might have been delayed another decade.
Monarch Vaporizer Pens (Vapes)
Jan 29, 2014 - SK3 Group, Inc.'s (SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that it has signed an exclusive distribution agreement for the Monarch Vaporizer from Monarch Vapes, a provider of portable personal vaporizers.
From 11/05/2013 conference call.
"We have management contracts in place to provide various managerial services and licenses to collectives that own or manufacture the medicines.
Our management contracts are a) with retail managed collectives that sell directly to patients and b) with wholesale managed collectives that take the raw material, that contains the medicine, and manufacture it into finished products, licensed in respect to manufacturing and marketing, and then sell these finished products to other dispensaries.
The wholesale managed collectives pay us a license fee for the intellectual property rights of products and processes for the creation of products such as Dharmanol and Canna-Loz, which license includes the right to use the name of the product and the formula for producing it.
Now, a great deal of time, effort and expertise have gone into developing these production methods so that they result in consistent products.
The beauty behind this whole thing is that we're exploiting these assets as licensors and consultants in the industry."
For Q3 (July 1 - Sept 30, 2013) per conference call 11/05/2013.
$17,527,592 in consulting, licensing and management fees
$4,510,893 net income pre-tax or $.0076/sh
O/S (inferred) 593,538,552 shares
Balance sheet
$129,865 cash and cash eqivalents
Receivables: net $22,569,699 after a reserve for $12,706,300 was established
